Meta-analysis of Efficacy and Safety Outcomes Associated With the Basal-Plus Regimen of Insulin Glargine and Insulin Glulisine among Type 2 Diabetes Patients With HbA1c≥8%

被引：0

|

作者：

Raccah, Denis

Lin, Jay

Bahloul, Amar

Wang, Edward

Penfornis, Alfred

机构：

来源：

DIABETES | 2012年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2464-PO

引用

收藏

页码：A620 / A620

页数：1

相关论文

共 50 条

[1] Efficacy and Safety of a Basal-Plus Regimen of Insulin Glargine Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 4 Clinical Trials
Del Prato, Stefano
Lankisch, Mark
Lin, Jay
Wang, Edward
Owens, David R.
[J]. DIABETES, 2012, 61 : A297 - A297
[2] Safety and efficacy of a basal-plus regimen with insulin glargine and insulin glulisine for elderly patients with high cardiovascular risk and type 2 diabetes mellitus
Gomez-Huelgas, R.
Saban-Ruiz, J.
Garcia-Roman, F. J.
Quintela-Fernandez, N.
Segui-Ripoll, J. M.
Bonilla-Hernandez, M. V.
Romero-Melia, G.
[J]. REVISTA CLINICA ESPANOLA, 2017, 217 (04): : 201 - 206
[3] Impact of Diabetes Duration on Efficacy and Safety of a Basal-Plus Regimen of Insulin Glargine Plus Once Daily Insulin Glulisine: A Pooled Analysis From 4 Clinical Trials
Owens, David R.
Del Prato, Stefano
Lin, Jay
Wang, Edward
Lankisch, Mark
[J]. DIABETES, 2012, 61 : A599 - A599
[4] Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus: Using insulin glargine as basal insulin
Kawamori, Ryuzo
Kadowaki, Takashi
Ishii, Hitoshi
Iwasaki, Manabu
Iwamoto, Yasuhiko
[J]. DIABETES, 2008, 57 : A573 - A573
[5] Efficacy of Insulin Glargine Plus 1 Injection of Insulin Glulisine in Patients with Type 2 Diabetes Inadequately Controlled by Insulin Glargine
Charpentier, Guillaume
[J]. DIABETES, 2014, 63 : A237 - A237
[6] Efficacy and safety of insulin glulisine and insulin lispro combined with insulin glargine in patients with Type 1 diabetes
Prager, R
Dreyer, M
Robinson, A
Busch, K
Penfornis, A
Souhami, E
[J]. DIABETOLOGIA, 2004, 47 : A301 - A301
[7] Efficacy and Safety of a Basal-Bolus Regimen of Basal Insulin Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 5 Clinical Trials
Dailey, George
Lin, Jay
Wang, Edward
[J]. DIABETES, 2012, 61 : A284 - A284
[8] A basal-bolus regimen of insulin glargine and insulin glulisine results in a lower rate of hypoglycaemia relative to endpoint HbA1c versus twice-daily premixed insulin in type 2 diabetes patients
Fritsche, A.
Larbig, M.
Haering, H. -U.
[J]. DIABETOLOGIA, 2010, 53
[9] SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS
Jammah, A.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A185 - A186
[10] Efficacy of combining insulin glulisine with basal insulin glargine in patients with Type 1 diabetes in everyday clinical practice
Fiesselmann, A.
Landgraf, W.
Schreiber, S.
[J]. DIABETIC MEDICINE, 2008, 25

← 1 2 3 4 5 →